Most people apply skincare the same way before a red light session as they do on any other morning: whatever they normally use, in whatever order they normally use it. The sequence is familiar. The mechanism is different.

Red light therapy at 625nm, particularly when delivered alongside controlled thermal output at approximately 42°C, does not leave the skin in its resting state. It changes the skin's permeability. That change is useful when the right ingredients are present at the skin surface. It creates a problem when the wrong ones are.

The serum question is not about which products are most expensive, or which ingredients are trending. It is about photochemistry: what each ingredient does when exposed to light and heat, and what that means for the skin during treatment.

The result is a brief window, roughly the duration of a contact treatment session, when the skin is measurably more permeable than baseline. Ingredients present at the surface during this window reach target tissue at greater concentrations than the same ingredient applied at any other point in the routine.

This is why pre-treatment serum selection matters. The enhanced absorption mechanism works on whatever is at the skin surface. The goal is to use it deliberately.

Some of the most commonly used skincare actives have significant problems when applied before red light therapy. The issues are chemical, not precautionary.

Retinoids (retinol, retinal, tretinoin): Retinoids are photosensitising. On exposure to ultraviolet light, retinol degrades via oxidation to retinyl hydroperoxide, a pro-oxidant species. While red light at 625nm is not UV radiation and does not drive the same photodegradation pathway, retinoids increase the skin's overall photosensitivity and temporarily compromise the skin barrier. This increases the risk of irritation during a treatment session, particularly when heat is also applied. Retinoids should be used in the evening routine, at least 30 minutes after treatment, not in the pre-treatment application window.

Ascorbic acid (unstabilised vitamin C): L-ascorbic acid is inherently unstable and oxidises readily on exposure to light and heat. At the skin surface, the oxidation product of ascorbic acid is dehydroascorbic acid and then diketogulonic acid, both of which are pro-inflammatory at higher concentrations. The distinction matters: stabilised vitamin C derivatives such as sodium ascorbyl phosphate are thermally and photostable and can be used both before and after a device session without this risk. This is why INFERA's Obsess C serum uses sodium ascorbyl phosphate rather than L-ascorbic acid — it is compatible at either point in the treatment sequence. Unstabilised L-ascorbic acid formulations are the ones to avoid in the same session as red light therapy.

AHAs and BHAs (glycolic acid, lactic acid, salicylic acid): Alpha and beta hydroxy acids exfoliate by breaking the bonds between corneocytes in the stratum corneum, which increases the skin's light and chemical sensitivity. Applying AHAs or BHAs before red light therapy increases photosensitivity and, under conditions of elevated thermal permeability, accelerates penetration of these acids into deeper tissue layers than intended. The result is a higher risk of irritation, redness, and barrier disruption. These actives should be used in the evening, not the pre-treatment window.

Heavy facial oils and thick occlusives: Not chemically problematic in the same way, but a practical issue. Thick oils and occlusive balms form a barrier on the skin surface that reflects light and prevents the glass applicator from making consistent contact. They should be applied post-treatment, not before.